logo

RCUS

Arcus BiosciencesยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

RCUS fundamentals

Arcus Biosciences (RCUS) released its earnings on Aug 6, 2025: revenue was 160.00M (YoY +310.26%), beat estimates; EPS was 0 (YoY +100.00%), beat estimates.
Revenue / YoY
160.00M
+310.26%
EPS / YoY
0
+100.00%
Report date
Aug 6, 2025
Earnings Call
4:05 PM on Aug 6, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

RCUS has released its 2025 Q3 earnings report, with revenue of 26.00M, reflecting a YoY change of -45.83%, and net profit of -135.00M, showing a YoY change of -46.74%. The Sankey diagram below clearly presents RCUS's revenue sources and cost distribution.

Key Indicators

Arcus Biosciences (RCUS) key financial stats and ratios, covering profitability, financial health, and leverage.
Arcus Biosciences (RCUS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Arcus Biosciences (RCUS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Arcus Biosciences (RCUS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Arcus Biosciences (RCUS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Arcus Biosciences (RCUS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield